Skip to main content

Want a detailed portfolio tracker?

Benitec Biopharma (BNTC) P/E (2020 - 2026)

Benitec Biopharma (BNTC) P/E from Jun 30, 2020 to Jul 21, 2026. The TTM Benitec Biopharma (BNTC) P/E is -8.68. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Benitec Biopharma (BNTC)

YearP/EChange
2026-8.68+2.47%
2025-8.47+83.06%
2024-4.63+1488.61%
2023-0.29+153.03%
2022-0.12-92.28%
2021-1.49+92.78%
2020-0.77N/A

Comparison Benitec Biopharma (BNTC) P/E with competitors

Benitec Biopharma (BNTC) P/E is -8.68.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.05%
ENLVEnlivex Ltd0.07-100.86%
FGENFibroGen Inc0.24-102.76%
CHRSCoherus Biosciences Inc0.85-109.77%
FBIOFortress Biotech Inc0.95-110.93%
ORMPOramed Pharmaceuticals Inc1.50-117.31%
AGENAgenus Inc3.01-134.66%
INVAInnoviva Inc3.15-136.33%
VXRTVaxart Inc3.55-140.88%
CRMDCorMedix Inc3.63-141.79%
CVACCureVac N.V.4.45-151.20%
GLPGGalapagos NV4.86-155.96%
SRPTSarepta Therapeutics Inc4.88-156.23%
ABEOAbeona Therapeutics Inc5.39-162.05%
ABUSArbutus Biopharma Corp5.60-164.45%
ZVRAZevra Therapeutics Inc5.89-167.81%
SPROSpero Therapeutics Inc6.23-171.74%
CGENCompugen Ltd6.31-172.72%
RIGLRigel Pharmaceuticals6.87-179.15%
SLXNSilexion Therapeutics Corp7.30-184.03%
OMEROmeros Corporation9.26-206.64%
AUPHAurinia Pharmaceuticals Inc9.58-210.39%
PLXProtalix BioTherapeutics Inc10.89-225.44%
ACADAcadia Pharmaceuticals Inc11.73-235.08%
TBPHTheravance Biopharma Inc12.26-241.23%
ADMAAdma Biologics Inc12.42-243.02%
HRMYHarmony Biosciences Holdings Inc13.82-259.17%
SABSSAB Biotherapeutics Inc14.14-262.81%
NAGENiagen Bioscience Inc14.82-270.67%
INCYIncyte Corp15.82-282.23%
REGNRegeneron Pharmaceuticals Inc15.86-282.63%
PBYIPuma Biotechnology Inc17.32-299.43%
CPRXCatalyst Pharmaceuticals Inc17.44-300.86%
EXELExelixis Inc17.54-301.99%
TGTXTG Therapeutics Inc18.97-318.44%
MDXGMimedx Group Inc20.55-336.71%
XOMAXOMA Royalty Corp22.87-363.46%
ARGXArgen X SE24.30-379.86%
CTMXCytomX Therapeutics Inc24.82-385.88%
XOMAOXOMA Royalty Corp25.34-391.91%
HALOHalozyme Therapeutics Inc25.62-395.13%
XOMAPXOMA Royalty Corp25.67-395.66%
VRTXVertex Pharmaceuticals Inc27.99-422.44%
RPRXRoyalty Pharma plc - Class A28.69-430.41%
SLNOSoleno Therapeutics Inc29.02-434.19%
ASNDAscendis Pharma A/S30.09-446.52%
LGNDLigand Pharmaceuticals Inc - Class B37.91-536.66%
APLSApellis Pharmaceuticals Inc39.02-549.43%
KRYSKrystal Biotech Inc45.34-622.25%
ONCBeiGene Ltd69.54-900.95%
PHARPharming Group N.V.75.03-964.12%
TECHBio-Techne Corp101.96-1274.33%
VCELVericel Corp109.92-1366.04%
ALNYAlnylam Pharmaceuticals Inc117.96-1458.69%
GMABGenmab140.29-1715.83%
TLXTelix Pharmaceuticals Ltd162.15-1967.63%
CORTCorcept Therapeutics Inc212.86-2551.63%